Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Present New Invoice Prices within 3 Days after New NHI Price Announcement: FJPWA
February 20, 2006
- HIV Drug Resistance Measurement Method Developed
February 20, 2006
- Managerial-level Workers at Pfizer Japan Form New Labor Union
February 20, 2006
- Astellas Licenses Prostate Cancer Treatment from Ferring
February 13, 2006
- 3 Switch-OTC Drugs Recommended for Approval
February 13, 2006
- R&D NEW IN BRIEF
February 13, 2006
- SELF-MEDICATION NEWS IN BRIEF
February 13, 2006
- National Burden Rate to Decline to 37.7% in FY2006
February 13, 2006
- Mochida: Moving Ahead with Priority on Profits, Forward-looking Investment
February 13, 2006
- Quintiles Expanding ECG Analysis Service in India
February 13, 2006
- Toho to Seek New Business Challenges Under Next 3-Year Plan
February 13, 2006
- Wako Pure Chemical: New Fecal Occult Blood Analyzer FOBITWAKO
February 13, 2006
- Sucampo Obtains FDA Approval for AMITIZA
February 13, 2006
- DPC Management Study Group Inaugurated
February 13, 2006
- BUSINESS NEWS IN BRIEF
February 13, 2006
- Korosho Announces Nutrition and Weight Gain GL for Pregnant, Nursing Mothers
February 13, 2006
- Focus on Pollinosis (2)
February 13, 2006
- JGPMA to Talk with JPMA About Job Sharing
February 13, 2006
- 2006 Pollen Websites
February 13, 2006
- Nationwide Delivery of Generics Is Possible: Mr Nakagawa
February 13, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…